Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Moderna Expands its mRNA Pipeline with Three New Development Programs
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of FusionPlex Dx® and LiquidPlex […]
A Study With Over 2,000 Cancers Missed by Screening Shows That Transpara AI Can Effectively Help Detect Breast Cancer Earlier
ScreenPoint Medical‘s Transpara AI decision support system can help radiologists to identify potential breast cancers […]
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases
AffaMed Therapeutics (“AffaMed”), a global clinical stage biotechnology company dedicated to developing and commercializing transformative […]
Bio-Rad Introduces Anti-Daratumumab Antibodies
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]
Biktarvy ® Demonstrates High Efficacy and Durable Viral Suppression at Five Years, in Treatment-Naïve Adults
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of cumulative 5-year results from two […]
Aromatase Inhibitors Cut Breast Cancer Recurrence in Younger Patients
Drugs called aromatase inhibitors reduce the risk of breast cancer returning by compared with oestrogen […]
GenesisCare Enrolls First Patients to SpaceOAR Vue™ Hydrogel Global Clinical Trial
GenesisCare—one of the leading oncology providers in the United States, Australia, Spain and the United […]
NHS Vaccination Lead Comments On Boosters Preventing An Estimated 105,000 Hospitalisations
Commenting on analysis published by the UKHSA today estimating that over 105,000 hospitalisations in people […]
Machine Learning Voice Tool Trialled to Help Manage Depression
Green Door Clinic – a specialist mental health clinic based in the Harley Street Medical […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more